← SynDRA
FLUNIXIN
SynDRA canonical compound SYN0025730 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Mechanism of action | prostanoid receptor antagonist |
|---|
| Indication | bovine respiratory disease (BRD) |
|---|
| Disease area | pulmonary |
|---|
All known targets
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- HDAC6
- ATAD5
- CYP1A2
- CYP2C19
- CYP2C9
- CYP2D6
- CYP3A4
- GMNN
- HIF1A
- SAMHD1
- TARDBP
- TDP1
- TSHR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- BLVRB
- CP1A2
- CP2C9
- ESRRA
- HDAC9
- PPARG
- RXRA
Drug classes
- Analgesics
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Antipyretics
- Antirheumatic Agents
- Peripheral Nervous System Agents
- Sensory System Agents
Cross-references
Synonyms
- Banamine
- Flunazine
- Flunine
- Vetameg
- SCH-14714
- flunixin meglumine
- Flunixine
- Flunixino
- Flunixinum
- CHEBI:76138
- 2(2'-Methyl-3'-trifluoromethylanilino)nicotinic acid
- Banamine-S
- Banamine Transdermal
- RefChem:57817
- DTXCID7028194
- 2-((2-Methyl-3-(trifluoromethyl)phenyl)amino)nicotinic acid
- 2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}nicotinic acid
- MFCD00072033
- Flunixin [USAN]
- Flunixine [INN-French]
- Flunixinum [INN-Latin]
- Flunixino [INN-Spanish]
- Flunixin [USAN:INN:BAN]
- 2-[[2-Methyl-3-(trifluoromethyl)phenyl]amino]nicotinic Acid
- Flunixin meglumin
- UNII-356IB1O400
- Cefquinome Impurity 2
- Flunixin (USAN/INN)
- FLUNIXIN [INN]
- FLUNIXIN [MI]
- Epitope ID:613430
- SCHEMBL42911
- MLS004712071
- FLUNIXIN [GREEN BOOK]
- orb1705362
- SCHEMBL29439899
- SCHEMBL31696761
- MSK7133
Look up FLUNIXIN in the interactive SynDRA portal →